Molecular Pharmacodynamics-Guided Scheduling of Biologically Effective Doses: A Drug Development Paradigm Applied to MET Tyrosine Kinase Inhibitors
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-0552
Full Text
Open PDFAbstract
Available in full text
Date
February 14, 2018
Authors
Publisher
American Association for Cancer Research (AACR)